- Lisapharma has appointed Dr Nicola Ottolina as its new Chief Executive Officer.
- Ottolina brings extensive sector knowledge and a results-focused approach to lead the company’s next phase of growth.
Lisapharma has announced the appointment of Dr Nicola Ottolina as its new Chief Executive Officer. The company described the decision as a step to guide the organisation into a new period of growth and stability.
Dr Ottolina has built his career within the organisation, progressing through a range of roles and responsibilities. According to Lisapharma, his professional journey has been marked by determination and steady advancement to reach the company’s top leadership position.
The appointment highlights his deep understanding of the sector and a practical, results-oriented vision. These qualities are seen by the company as key assets in steering Lisapharma’s strategy and operations.
